---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "PSpzuGi3cZ8hhGjefYdygGr+qVrM+edVXY1gQZ07vjVDGzVYQgUeUQy910Qj5oYoVBGYVfdWqMmU2pH2or4oI3olwMMG6mXObhU6e+ud0uwPZa/F0xauHv3L/N1jUdVb0VenIzeNQfLvzvrlBHWC7+2e53hqdY5G+Mx3WVU9pQdcXxkr/1wF557yIgA6xF2im5KJsvSSQP7r4japkEi0ukylhjFbzmXyBFuCnOMj+Q1KJy+D+DamnpygrUqVUO8mRRiX2S65Gfu6M46q260nQ14zTc5WBddNZ0mMbvVpwKuzkdnKK8ZgwO3I8X68RepNhysDbGbZ8EqSHR+iuQaTbE9m5HRswvNLeo+xPI5MAoU=;4plREHkfjVDc/j2eB4FlSQ=="
---

